Owners, management and financials
CVR: 29428689
Secondary names: EUROFINS PHARMA A/S, EUROFINS PHARMA QUALITY CONTROL DENMARK A/S, Eurofins Professional Scientific Services Denmark A/S
Previous names: EUROFINS FOOD & PHARMA A/S, EUROFINS PHARMA A/S, EUROFINS PHARMA QUALITY CONTROL DENMARK A/S
DKK 76,588,460
Gross profit
Net result: DKK 10,230,696
Eurofins BioPharma Product Testing Denmark Holding A/S (100%)
CVR · view owners
Jan Rando
Board: Svend Aage Linde (chair) and 5 members
CVR · view management
Active
Founded 16 March 2006
CVR · view overview
96 employees
CVR · 2026
Director role ended: Jacob Klinge Jacobsen
CVR · 01/07/2018
View the full event history
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S is a Danish company of the type Aktieselskab based in Galten, founded in 2006. The company is registered under the industry Kontrol af levnedsmidler. The company was previously named EUROFINS PHARMA QUALITY CONTROL DENMARK A/S and EUROFINS PHARMA A/S. The management consists of Jan Rando. The board consists of Svend Aage Linde (chair), Jacob Sickmann Ransborg, Jan Rando and Mette Aaby Kramhöft. The company is owned by Eurofins BioPharma Product Testing Denmark Holding A/S. The company has 96 employees (2026). In 2025, the company reported a gross profit of DKK 76,588,460 and a net result of DKK 10,230,696 compared with DKK 10,742,824 the year before. Equity in the 2025 report amounted to DKK 22,987,075.
Source: annual report 2025, Danish Business Authority
The financial health of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S appears strong, with a consistent gross profit growth from 54.5 million DKK in 2023 to 76.6 million DKK in 2025. Profitability has fluctuated, peaking at 11.6 million DKK in 2021 and stabilizing around 10 million DKK in recent years, indicating resilience despite market challenges. The company's equity has shown a positive trend, increasing from 12.8 million DKK in 2023 to nearly 23 million DKK in 2025, reflecting a solid capital base. However, the absence of revenue data limits a full assessment of operational scale, though the increasing gross margins suggest effective cost management within the food safety testing industry.
AI-generated summary · Generated 14/08/2026
Selskabets formål er at tilbyde GxP laboratorie- og hertil relaterede ydelser til farmaceutiske, Biopharmaceutiske og Medical device virksomheder i overensstemmelse med globalt gældende GxP regler.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 76.6M | 10.2M | 80.5M | 23M | 95 | |
| 202401/01/2024 – 31/12/2024 | 65M | 10.7M | 86.6M | 22.6M | 90 | |
| 202301/01/2023 – 31/12/2023 | 54.5M | 1.2M | 64.5M | 12.8M | 90 | |
| 202201/01/2022 – 31/12/2022 | 64.5M | 9.5M | 60.9M | 18.1M | 95 | |
| 202101/01/2021 – 31/12/2021 | 56.8M | 11.6M | 49.3M | 18.5M | 78 | |
| 202001/01/2020 – 31/12/2020 | 51.6M | 9.8M | 44.9M | 13M | 71 | |
| 201901/01/2019 – 31/12/2019 | 41.7M | 7.2M | 29.8M | 10.2M | 67 | |
| 201801/01/2018 – 31/12/2018 | 38.3M | 5M | 29.4M | 8M | 64 | |
| 201701/01/2017 – 31/12/2017 | 42.8M | 9.8M | 35.5M | 12.8M | - | |
| 201601/01/2016 – 31/12/2016 | 29M | 3.4M | 23.7M | 5.9M | - | |
| 201501/01/2015 – 31/12/2015 | 25.4M | 2.3M | 20.5M | 5M | - | |
| 201401/01/2014 – 31/12/2014 | 24.8M | 2.9M | 21.6M | 5.7M | - | |
| 201301/01/2013 – 31/12/2013 | 22.6M | 1.8M | 18.4M | 2.8M | - | |
| 201201/01/2012 – 31/12/2012 | 18.6M | -1.3M | 18.2M | 1.1M | - |
Compared to 11 companies in Kontrol af levnedsmidler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S is 29428689.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S is owned by Eurofins BioPharma Product Testing Denmark Holding A/S.
The management of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S consists of Jan Rando.
The board of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S consists of Svend Aage Linde, Jacob Sickmann Ransborg and Jan Rando, with Svend Aage Linde as chair.
In 2025, EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S reported a gross profit of DKK 76,588,460.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S had 96 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2025. Gross profit came to DKK 76,588,460, and the net result was DKK 10,230,696.
As of May 19, 2026, Mette Aaby Kramhöft has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of May 19, 2026, Jeppe Andersen Jacomo has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of May 18, 2026, Mette Aaby Kramhöft has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2024. Gross profit came to DKK 64,991,261, and the net result was DKK 10,742,824.
As of March 6, 2025, Jacob Sickmann Ransborg has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of March 6, 2025, Stefánia Pcolová has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of March 3, 2025, Mette Aaby Kramhöft has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of March 3, 2025, Nadja Sun Wissing has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of March 3, 2025, Jeppe Andersen Jacomo has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of March 2, 2025, Nadja Sun Wissing has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2023. Gross profit came to DKK 54,476,694, and the net result was DKK 1,246,608.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2022. Gross profit came to DKK 64,507,271, and the net result was DKK 9,511,878.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2021. Gross profit came to DKK 56,810,470, and the net result was DKK 11,554,729.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2020. Gross profit came to DKK 51,638,638, and the net result was DKK 9,756,940.
As of October 29, 2020, Nadja Sun Wissing has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of October 29, 2020, Stina Hansen has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of October 29, 2020, Steen Høpfner has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of October 29, 2020, Christina Daugbjerg Roden Nielsen has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2019. Gross profit came to DKK 41,727,699, and the net result was DKK 7,248,430.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2018. Gross profit came to DKK 38,294,431, and the net result was DKK 5,033,465.
As of May 10, 2019, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of May 10, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of October 15, 2018, Jan Rando has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of October 15, 2018, Jacob Klinge Jacobsen has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of July 1, 2018, Jan Rando is registered as adm. dir. of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of July 1, 2018, Jacob Klinge Jacobsen has stepped down as adm. dir. of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2017. Gross profit came to DKK 42,835,919, and the net result was DKK 9,825,945.
As of January 26, 2018, Stefánia Pcolová has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of January 1, 2018, Thomas Gjelsnes has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2016. Gross profit came to DKK 28,957,383, and the net result was DKK 3,437,688.
As of December 29, 2016, Eurofins BioPharma Product Testing Denmark Holding A/S is registered as an owner of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S with an ownership share of 100%.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2015. Gross profit came to DKK 25,436,949, and the net result was DKK 2,281,076.
As of January 21, 2016, Christina Daugbjerg Roden Nielsen has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
On December 8, 2015, the company changed its name from EUROFINS PHARMA QUALITY CONTROL DENMARK A/S to EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of August 31, 2015, Michael Timm has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of August 13, 2015, Thomas Gjelsnes has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of August 13, 2015, Lars Christian Caspersen has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2014. Gross profit came to DKK 24,845,908, and the net result was DKK 2,867,256.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2013. Gross profit came to DKK 22,619,705, and the net result was DKK 1,750,125.
As of March 26, 2014, Michael Timm has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of March 26, 2014, Christina Daugbjerg Roden Nielsen has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S has published its annual report for 2012. Gross profit came to DKK 18,649,604, and the net result was DKK -1,348,300.
As of April 1, 2013, Anette Jeppesen has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of May 29, 2012, Karsten Krogh Jørgensen has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
On December 9, 2011, the company changed its name from EUROFINS PHARMA A/S to EUROFINS PHARMA QUALITY CONTROL DENMARK A/S.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of May 6, 2011, Jacob Klinge Jacobsen has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of May 6, 2011, Ole Møller has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of February 28, 2009, Lars Christian Caspersen has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of February 28, 2009, Henning Stensgaard Jensen has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of December 12, 2008, Christina Daugbjerg Roden Nielsen has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of December 12, 2008, Anette Jeppesen has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of December 12, 2008, Lene Østerby has left the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of May 27, 2008, A/S PSE NR. 4820 has been appointed auditor of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of May 27, 2008, A/S PSE 17 NR. 1056 has stepped down as auditor of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of August 2, 2007, Jacob Klinge Jacobsen is registered as adm. dir. of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of August 2, 2007, John Birger Engelhardt has stepped down as adm. dir. of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of June 28, 2007, Steen Høpfner has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of June 28, 2007, Lene Østerby has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
On February 19, 2007, the company changed its name from EUROFINS FOOD & PHARMA A/S to EUROFINS PHARMA A/S.
As of May 29, 2006, Svend Aage Linde has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of May 29, 2006, Karsten Krogh Jørgensen has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of May 29, 2006, John Birger Engelhardt is registered as adm. dir. of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of May 29, 2006, Svend Aage Linde has stepped down as adm. dir. of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of March 16, 2006, A/S PSE 17 NR. 1056 has been appointed auditor of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of March 16, 2006, Henning Stensgaard Jensen has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of March 16, 2006, Ole Møller has joined the board of directors of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
As of March 16, 2006, Svend Aage Linde is registered as adm. dir. of EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S.
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S was founded on March 16, 2006.
Companies in the same industry and area
CVR 36461217
CVR 38277308
CVR 38277383
CVR 87373010
CVR 18742284
